UNC9994

UNC9994 is a **small molecule** that acts as a **functionally selective, β-arrestin-biased agonist at the dopamine D2 receptor (D2R)**. It is structurally an analog of aripiprazole, featuring a benzothiazole core linked to a piperidine ring via a propoxy linker[9][6]. Unlike typical D2R ligands, UNC9994 preferentially activates **β-arrestin2-mediated signaling** at D2R, with little to no activation of classical Gi/o protein pathways under some conditions[1][4][6]. However, recent evidence indicates it acts as a **partial agonist at G protein-coupled inward rectifier potassium channel activation** at both dopamine D2 and D3 receptors, with more activity at D3[3][2]. In animal models, UNC9994 demonstrates **robust antipsychotic drug-like effects** without typical motoric side effects, and its efficacy is **dependent on β-arrestin2**, making it a valuable tool for studying GPCR signaling biases and a potential candidate for novel antipsychotic development[4][7]. Primary research has focused on its application for **schizophrenia** and related disorders[5][10].